Inotiv Inc., a leading contract research organization specializing in drug discovery and development services, has announced a strategic partnership with VUGENE, a multi-omics data analysis company. Through this collaboration, Inotiv will integrate VUGENE's cloud-based bioinformatics and computational platform into its Discovery & Translational Sciences Division. The partnership aims to enhance Inotiv's capabilities in analyzing complex biological data, including epigenomic and proteomic datasets, and to accelerate AI-assisted drug discovery. Both companies expect the alliance to improve the prediction of drug efficacy and safety in early-stage research and to help clients make faster, more informed decisions.